机构：[1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University.[2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province.[3]Laboratory for Targeted Radiopharmaceuticals Creation.[4]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.
Luzhou Science and Technology plan
projects (2022-JYJ-118, 2021LZXNYD-C02, and 2021LZXNYDP03) and a major science and technology project in Gansu Province
(23ZDFA014).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2025]版：
大类|3 区医学
小类|3 区核医学
最新[2025]版：
大类|3 区医学
小类|3 区核医学
第一作者：
第一作者机构：[1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University.[2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province.[3]Laboratory for Targeted Radiopharmaceuticals Creation.[4]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University.[2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province.[3]Laboratory for Targeted Radiopharmaceuticals Creation.[4]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.
推荐引用方式(GB/T 7714)：
Zhang Na,Li Linwei,Liu Huipan,et al.Increased Uptake of 68Ga-DOTA-IBA in Lung NUT Carcinoma[J].Clinical Nuclear Medicine.2025,doi:10.1097/RLU.0000000000005902.
APA：
Zhang Na,Li Linwei,Liu Huipan,Xu Tingting&Chen Yue.(2025).Increased Uptake of 68Ga-DOTA-IBA in Lung NUT Carcinoma.Clinical Nuclear Medicine,,
MLA：
Zhang Na,et al."Increased Uptake of 68Ga-DOTA-IBA in Lung NUT Carcinoma".Clinical Nuclear Medicine .(2025)
